What is the current Price Target for the Amylyx Pharmaceuticals stock?

The average Amylyx Pharmaceuticals target price is $42.84. This is 52.56% higher than the current stock price. The highest price target is 113.14%, the lowest is -28.06%. 13 Analysts have issued a price target Amylyx Pharmaceuticals 2027 .

How high will the Amylyx Pharmaceuticals stock rise?

No reliable answer can be given as to how high the Amylyx Pharmaceuticals stock will rise. The performance of stocks, including the Amylyx Pharmaceuticals stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Amylyx Pharmaceuticals stock today?

The performance of Amylyx Pharmaceuticals stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Amylyx Pharmaceuticals stock fall?

The decline in Amylyx Pharmaceuticals stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Amylyx Pharmaceuticals Forecast, price target & analysts

$28.08

3.51%

NYSE, Oct 01, 04:00 pm EDT. Closed.

ISIN

US03237H1014

Symbol

AMLX

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Amylyx Pharmaceuticals Target price 2026 - Analyst rating & recommendation

Amylyx Pharmaceuticals Classifications & Recommendation

Buy

89%

Hold

11%

Amylyx Pharmaceuticals Price Target

Target Price	$42.84
Price	$28.08
Potential	52.56% register free of charge
Number of Estimates	13

	13 Analysts have issued a price target Amylyx Pharmaceuticals 2027 . The average Amylyx Pharmaceuticals target price is $42.84. This is 52.56% register free of charge higher than the current stock price. The highest price target is $59.85 113.14% register free of charge , the lowest is $20.20 28.06% register free of charge .
	A rating was issued by 18 analysts: 16 Analysts recommend Amylyx Pharmaceuticals to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Amylyx Pharmaceuticals stock has an average upside potential 2027 of 52.56% register free of charge . Most analysts recommend the Amylyx Pharmaceuticals stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.53	-1.55
	65.46%	1.31%
P/E		negative

12 Analysts have issued a Amylyx Pharmaceuticals forecast for earnings per share. The average Amylyx Pharmaceuticals EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.53	65.46%
2026	$-1.55 1.31% unlock
2027	$-1.45 6.45% unlock
2028	$-0.36 75.17% unlock
2029	$0.77 313.89% unlock
2030	$2.10 172.73% unlock
2031	$2.76 31.43% unlock
2032	$3.75 35.87% unlock
2033	$4.09 9.07% unlock

Current	-20.65	198.61%
2026	-18.15 12.09% unlock
2027	-19.33 6.50% unlock
2028	-78.50 306.10% unlock
2029	36.55 146.56% unlock
2030	13.34 63.50% unlock
2031	10.18 23.69% unlock
2032	7.49 26.42% unlock
2033	6.87 8.28% unlock

Amylyx Pharmaceuticals...

Current Amylyx Pharmaceuticals Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Aug 27 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 19 2026
Baird	Locked ➜ Locked	Locked	Aug 19 2026
Mizuho	Locked ➜ Locked	Locked	Aug 19 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 18 2026
Mizuho	Locked ➜ Locked	Locked	Aug 17 2026
Citigroup	Locked ➜ Locked	Locked	Aug 03 2026

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Aug 27 2026
Locked Guggenheim: Locked ➜ Locked	Aug 19 2026
Locked Baird: Locked ➜ Locked	Aug 19 2026
Locked Mizuho: Locked ➜ Locked	Aug 19 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 18 2026
Locked Mizuho: Locked ➜ Locked	Aug 17 2026
Locked Citigroup: Locked ➜ Locked	Aug 03 2026

Discover more stocks with a high price target

NIO ADR 85.25%

Alibaba Group Holding Ltd 78.14%

Rheinmetall 72.55%

Tencent Holdings Ltd. 57.61%

Adyen 57.36%

Infineon 55.35%

Uber Technologies 51.77%

BYD 46.92%

Siemens Energy 46.72%

TUI 45.17%

Adidas 43.01%

Netflix 42.06%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now